<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02715674</url>
  </required_header>
  <id_info>
    <org_study_id>41268</org_study_id>
    <nct_id>NCT02715674</nct_id>
  </id_info>
  <brief_title>Comparison the Effectiveness of Postoperative Incentive Spirometry and Noninvasive Mechanical Ventilation in Patients Following Craniotomy</brief_title>
  <official_title>Comparison the Effectiveness of Postoperative Incentive Spirometry and Noninvasive Mechanical Ventilation in Patients Following Craniotomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare the effectiveness of postoperative incentive spirometry and
      noninvasive mechanical ventilation on pulmonary functions after craniotomy in 60 patients.
      Patients were randomized into a control group (G-K, n:20), an IS group (G-IS, n:20) and a
      CPAP (continuous positive airway pressure) group (G-CPAP, n:20)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will compare the effectiveness of postoperative incentive spirometry and
      noninvasive mechanical ventilation on pulmonary functions after craniotomy in 60 patients.
      Patients were randomized into a control group (G-K, n:20), an IS group (G-IS, n:20) and a
      CPAP (continuous positive airway pressure) group (G-CPAP, n:20).

      The investigators included male or female, between 18 and 60 years old, American Society of
      Anesthesiologists score 1, 2 patients in this study. The investigator excluded patients with
      significant cardiopulmonary disease like myocardial infarction, obstructive or restrictive
      pulmonary disease, liver or kidney failure, chest wall deformities, postoperative lack of
      cooperation from this study. In postoperatively, control group will take 4lt/min oxygen with
      Plasti-med oxygen therapy mask for 6 hours, IS group will carry out Plasti-med TRIFLO 5 min
      per hour for 6 hours, CPAP group will carry out 10 cmH2O noninvasive continuous positive
      airway pressure with BIPAP VISION 5 min per hour for 6 hours. Lung functions and arterial
      blood gas analysis will be recorded preoperative baseline, postoperative 1st, 6th and 24th
      hours.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">November 2016</completion_date>
  <primary_completion_date type="Anticipated">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline forced expiratory volume at one second (FEV1) % predicted (no unit)</measure>
    <time_frame>preoperative baseline, postoperative 1st, 6th and 24th hours</time_frame>
    <description>The investigators will use Spirolab 3 COLOUR LCD device for measurement.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline forced vital capacity (FVC) % predicted (no unit)</measure>
    <time_frame>preoperative baseline, postoperative 1st, 6th and 24th hours</time_frame>
    <description>The investigators will use Spirolab 3 COLOUR LCD device for measurement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline FEV1/FVC ratio (no units)</measure>
    <time_frame>preoperative baseline, postoperative 1st, 6th and 24th hours</time_frame>
    <description>The investigators will use Spirolab 3 COLOUR LCD device for measurement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline partial arterial oxygen pressure( PaO2) (mmHg)</measure>
    <time_frame>preoperative baseline, postoperative 1st, 6th and 24th hours</time_frame>
    <description>The investigators will use Cobas B 221 device for measurement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline partial arterial carbondioxide pressure (PaCO2) (mmHg)</measure>
    <time_frame>preoperative baseline, postoperative 1st, 6th and 24th hours</time_frame>
    <description>The investigators will use Cobas B 221 device for measurement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline power of hydrogen (pH)</measure>
    <time_frame>preoperative baseline, postoperative 1st, 6th and 24th hours</time_frame>
    <description>The investigators will use Cobas B 221 device for measurement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline arterial oxygen saturation (SaO2) (%)</measure>
    <time_frame>preoperative baseline, postoperative 1st, 6th and 24th hours</time_frame>
    <description>The investigators will use Cobas B 221 device for measurement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline base excess (BE) (mmol/L)</measure>
    <time_frame>preoperative baseline, postoperative 1st, 6th and 24th hours</time_frame>
    <description>The investigators will use Cobas B 221 device for measurement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline bicarbonate (HCO3) (mmol/L)</measure>
    <time_frame>preoperative baseline, postoperative 1st, 6th and 24th hours</time_frame>
    <description>The investigators will use Cobas B 221 device for measurement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline PaO2/FiO2 ratio (no units)</measure>
    <time_frame>preoperative baseline, postoperative 1st, 6th and 24th hours</time_frame>
    <description>The investigators will calculate PaO2/FiO2 ratio</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Neoplasms, Intracranial</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>take 4lt/min oxygen with Plasti-med oxygen therapy mask</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IS group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>in postoperatively, patients will carry out Plasti-med TRIFLO 5 min per hour for 6 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CPAP group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>in postoperatively, patients will carry out 10 cmH2O noninvasive continuous positive airway pressure with BIPAP VISION 5 min per hour for 6 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Plasti-med TRIFLO</intervention_name>
    <arm_group_label>IS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BIPAP VISION</intervention_name>
    <arm_group_label>CPAP group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Plasti-med oxygen therapy mask</intervention_name>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists score 1, 2 patients

        Exclusion Criteria:

          -  Patients with significant cardiopulmonary disease like myocardial infarction,
             obstructive or restrictive pulmonary disease, liver or kidney failure, chest wall
             deformities, postoperative lack of cooperation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ozlem KORKMAZ DILMEN, Asst. Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Istanbul University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hulya KAHRAMAN SAH, MD</last_name>
    <phone>00905064214301</phone>
    <email>drhulyakahraman@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Istanbul University Cerrahpasa Medical Faculty Neurosurgery Department</name>
      <address>
        <city>Istanbul</city>
        <zip>34098</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ozlem KORKMAZ DILMEN, Asst. Prof.</last_name>
      <phone>00902124143000</phone>
      <phone_ext>1745</phone_ext>
      <email>korkmazdilmen@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Eren F Akcil, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yusuf Tunali, Prof.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 23, 2016</study_first_submitted>
  <study_first_submitted_qc>March 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 22, 2016</study_first_posted>
  <last_update_submitted>March 21, 2016</last_update_submitted>
  <last_update_submitted_qc>March 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul University</investigator_affiliation>
    <investigator_full_name>HULYA KAHRAMAN SAH</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

